INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

412 studies · page 4 of 18

2018 / Randomised, placebo-controlled, crossover study

Curcumin, alone or with fish oil, significantly reduced postprandial glucose and insulin responses in healthy individuals.

A randomised, placebo-controlled, crossover trial examined the effects of a single dose of placebo, curcumin (180 mg), fish oil (1.2 g LC n-3 PUFA), or curcumin plus fish oil before a standard meal in 16 healthy participants across 4 test days. At 60 minutes, postprandial glucose was significantly lower with curcumin (60.6%, P = 0.0007) and curcumin plus fish oil (51%, P = 0.002). Compared to placebo, blood glucose AUC was reduced by curcumin (36%, P = 0.003) and curcumin plus fish oil (30%, P = 0.004), but not fish oil alone (P = 0.105). Postprandial insulin AUC was also significantly reduced by 26% with both curcumin (P = 0.01) and curcumin plus fish oil (P = 0.03).

Thota RN, Dias CB, Abbott KA, et al. Sci Rep, 2018. PMID 30209353

2018 / Randomized crossover trial

Moringa oleifera leaf powder added to a traditional meal lowered postprandial glycemic response in Saharawi diabetic subjects but not in healthy subjects.

On two different days, 17 Saharawi diabetic subjects and 10 healthy subjects were randomly administered a traditional meal supplemented with 20 g of Moringa oleifera (MO) leaf powder or a control meal without MO. Capillary glycaemia was measured before the meal and at 30 min intervals for 3 h. In diabetic subjects, the postprandial glucose response peaked earlier with the 20 g MO meal compared to control, showed lower increments at 90, 120, and 150 min, and had a lower mean glycemic response. No differences were seen in healthy subjects. The abstract notes poor taste acceptability of the 20 g MO meal.

Leone A, Bertoli S, Di Lello S, et al. Nutrients, 2018. PMID 30322091

2018 / Self-controlled clinical trial

Foxtail millet intake was followed by reduced blood glucose in impaired glucose tolerance

In a self-controlled clinical study, adults with impaired glucose tolerance consumed 50 g daily of foxtail millet for 12 weeks. Following the intervention, fasting blood glucose dropped from 5.7 ± 0.9 mmol/L to 5.3 ± 0.7 mmol/L (p < 0.001) and 2-hour glucose fell from 10.2 ± 2.6 mmol/L to 9.4 ± 2.3 mmol/L (p = 0.003). Circulating leptin increased (p = 0.012) while insulin resistance declined (p = 0.007).

Ren X, Yin R, Hou D, et al. Nutrients, 2018. PMID 30326632

2018 / Randomized controlled trial

A low-carbohydrate diet combined with HIIT yielded the greatest percentage improvements in glucose, cholesterol, weight, and several inflammatory markers in obese T2D patients.

Researchers randomized inactive obese patients with type 2 diabetes into three experimental diet groups (low-carbohydrate [LCD], low-fat [LFD], high-fat [HFD]; n=11 each) and a normal diet control group (n=9) over 24 weeks combining diets with 12 weeks of cycle-ergometer HIIT. After 24 weeks, the highest percentage improvements were seen in LCD for glucose (-34.76%), cholesterol (-33.35%), HDL (+41.81%), triglycerides (-40.71%), and weight (-12.49%). The highest percentage reductions in IL-6 (-32.10%), resistin (-28.29%), and leptin (-53.92%) occurred in the LCD group, while LFD showed the largest improvements in TNF-alpha (-48.06%), FGF21 (+55.30%), and adiponectin (+42.32%).

Asle Mohammadi Zadeh M, Kargarfard M, Marandi SM, et al. J Diabetes Metab Disord, 2018. PMID 30918861

2017 / Randomized, double-blinded crossover trial

A replacement diet with organic ancient khorasan wheat improved metabolic and inflammatory risk factors in type 2 diabetes patients.

In a randomized, double-blinded crossover trial, 21 patients with type 2 diabetes consumed products made from organic ancient khorasan wheat or modern organic control wheat for 8 weeks each, separated by an 8-week washout. The metabolic risk profile improved only after the khorasan intervention, with mean reductions in total cholesterol (-3.7%), LDL cholesterol (-3.4%), insulin (-16.3%), and blood glucose (-9.1%). Khorasan wheat also significantly reduced reactive oxygen species, VEGF, and interleukin-1ra, and increased total antioxidant capacity (+6.3%), whereas modern wheat produced no significant differences from baseline.

Whittaker A, Dinu M, Cesari F, et al. Eur J Nutr, 2017. PMID 26853601

2017 / Randomized controlled trial

Fresh yellow onion intake lowered fasting glucose and insulin resistance during breast cancer chemotherapy.

Eligible breast cancer patients receiving doxorubicin-based chemotherapy were randomized to an 8-week intervention with high daily onion intake (100 to 160 g/d) or low daily onion intake (30 to 40 g/d). Analyses of 23 participants per group revealed that high onion intake significantly decreased fasting blood glucose and insulin levels relative to low onion intake (P < .001). Post-treatment insulin resistance assessed by HOMA-IR was also significantly lower in the high onion group (P < .05).

Jafarpour-Sadegh F, Montazeri V, Adili A, et al. Integr Cancer Ther, 2017. PMID 27352956

2017 / Randomized double-blind placebo-controlled trial

Chlorella vulgaris supplementation affected weight and glucose changes in fatty liver disease

Seventy patients with non-alcoholic fatty liver disease were randomized to receive 1,200 mg daily of Chlorella vulgaris or placebo for 8 weeks. Weight reduction was significantly greater in the supplemented arm compared to placebo. Between-group differences in mean changes were significant for serum glucose and TNF-α after adjusting for baseline values and insulin (reported adjusted P-values: 0.014, 0.005, 0.014), but not for other measured outcomes.

Ebrahimi-Mameghani M, Sadeghi Z, Abbasalizad Farhangi M, et al. Clin Nutr, 2017. PMID 27475283

2017 / Randomized controlled trial

Replacing diet beverages with water after lunch may lead to greater weight reduction in obese women with type 2 diabetes.

In an 81-patient randomized trial of overweight and obese women with type 2 diabetes on a weight loss program, replacing diet beverages with water after lunch 5 times per week resulted in greater decreases in weight (-6.40 ± 2.42 kg vs -5.25 ± 1.60 kg; P = .006) and BMI (-2.49 ± 0.92 kg/m2 vs -2.06 ± 0.62 kg/m2; P = .006) over 24 weeks compared to continuing diet beverages. The water group also achieved significantly greater reductions in fasting plasma glucose, fasting insulin, HOMA-IR, and 2-hour postprandial glucose. However, no significant time × group interaction was found for waist circumference, lipid profiles, or HbA1c.

Madjd A, Taylor MA, Delavari A, et al. Diabetes Obes Metab, 2017. PMID 27748014

2017 / Crossover trial

Adding 30 g of insoluble dietary fiber to a high-fat high-calorie meal reduced postprandial inflammatory and ROS responses in normal fasting subjects.

Ten normal fasting subjects consumed a high-fat, high-calorie (HFHC) meal with or without 30 g of insoluble dietary fiber across two visits, with blood sampled over 5 hours. Adding fiber significantly lowered glucose excursion in the first 90 minutes and increased insulin and C-peptide secretion over the 5-hour period compared with the meal alone. The fiber addition prevented increases in lipopolysaccharide (LPS) and significantly reduced meal-induced increases in reactive oxygen species generation, as well as the expression of IL-1β, TNF-α, TLR-4, CD14, SOCS-3, and PTP-1B.

Ghanim H, Batra M, Abuaysheh S, et al. J Clin Endocrinol Metab, 2017. PMID 27906549

2017 / Randomized crossover trial

Non-nutritive sweeteners did not reduce total daily energy intake compared with sucrose.

A randomized crossover trial in 30 healthy men compared mid-morning preloads sweetened with aspartame, monk fruit, stevia, or sucrose (65 g). Ad libitum lunch intake was higher after non-nutritive sweetener drinks than sucrose (P = 0.010), leading to full compensation and no difference in total daily energy intake (P = 0.831). Three-hour total area under the curve for glucose (P = 0.960) and insulin (P = 0.216) did not differ among the four beverages.

Tey SL, Salleh NB, Henry J, et al. Int J Obes (Lond), 2017. PMID 27956737

2017 / Randomized controlled crossover trial

Both Salba-chia and flax seeds lowered postprandial blood glucose, but Salba-chia altered peak glucose kinetics and reduced appetite more than flax.

Fifteen healthy participants received a 50 g glucose challenge alone or supplemented with either 25 g ground Salba-chia or 31.5 g flax on three separate occasions. Both Salba-chia and flax reduced the 120-min blood glucose area under the curve by 82.5±19.7 mmol/l (P<0.001) and 60.0±19.7 mmol/l (P=0.014), respectively, relative to control. Compared with flax, Salba-chia reduced peak glucose by -0.64±0.24 mmol/l (P=0.030), increased time to peak by 11.3±3.8 min (P=0.015), and significantly reduced overall appetite score (-6±2 mm; P=0.012). Viscosity was 49.9 Pa·s for Salba-chia, 2.5 Pa·s for flax, and 0.002 Pa·s for control.

Vuksan V, Choleva L, Jovanovski E, et al. Eur J Clin Nutr, 2017. PMID 28000689

2017 / Randomized crossover trial

Adding freeze-dried strawberry powder to a high-fat meal did not alter postprandial vascular markers.

A randomized crossover trial in 30 overweight or obese adults assessed the impact of adding 40 g of freeze-dried strawberry powder to a high-fat meal. No significant differences appeared between the strawberry and control meals for any vascular or metabolic outcome. Both meals similarly reduced the augmentation index at 2 and 4 hours (P < 0.002) and increased postprandial triglycerides, insulin, and glucose relative to baseline (P < 0.001).

Richter CK, Skulas-Ray AC, Gaugler TL, et al. Am J Clin Nutr, 2017. PMID 28003205

2017 / Randomized controlled trial

Salba-chia added to calorie restriction aids weight and waist loss in diabetes.

In a 6-month trial involving 77 overweight or obese adults with type 2 diabetes, participants received either Salba-chia or an oat bran control alongside a calorie-restricted regimen. Those receiving Salba-chia achieved greater weight loss (1.9 ± 0.5 kg vs. 0.3 ± 0.4 kg; P = 0.020) and greater waist circumference reductions (3.5 ± 0.7 cm vs. 1.1 ± 0.7 cm; P = 0.027). Salba-chia also produced superior decreases in C-reactive protein (P = 0.045) and increased adiponectin levels (P = 0.022).

Vuksan V, Jenkins AL, Brissette C, et al. Nutr Metab Cardiovasc Dis, 2017. PMID 28089080

2017 / Randomized controlled trial

An acute saturated fat load induced insulin resistance and increased hepatic lipid storage.

A randomized trial in 14 lean, healthy individuals evaluated the metabolic impacts of an oral palm oil challenge compared with vehicle. Palm oil lowered insulin sensitivity across the whole body by 25%, liver by 15%, and adipose tissue by 34%. It also boosted liver triglyceride stores by 35%, increased ATP levels by 16%, and elevated gluconeogenesis by 70%, while decreasing glycogenolysis by 20%.

Hernández EÁ, Kahl S, Seelig A, et al. J Clin Invest, 2017. PMID 28112681

2017 / Randomized crossover trial

Short-term carbohydrate overfeeding, without protein restriction, markedly increased circulating FGF21 levels in healthy men.

Nine healthy men were fed three diets for three days each in random order: a eucaloric control diet (CON), a carbohydrate-rich diet (+75% energy, 80 E% carbohydrate; CHO), and a fat-rich diet (+75% energy, 78 E% fat; FAT), maintaining similar absolute protein intake between CHO and CON. Plasma FGF21 increased 8-fold after CHO compared to CON (329 ± 99 vs. 39 ± 9 pg ml-1, p < 0.05), whereas FAT produced only a non-significant tendency to increase (p = 0.073). The increase in FGF21 after CHO correlated closely (r = 0.88, p < 0.01) with increased leg glucose uptake (62%, p < 0.05) and hepatic glucose production (17%, p < 0.01). CHO also decreased plasma fatty acids by 68% (p < 0.01), increased the de novo lipogenesis marker C16:1 n-7 FA by 146% (p < 0.01), and increased plasma triglycerides by 101% (p < 0.001).

Lundsgaard AM, Fritzen AM, Sjøberg KA, et al. Mol Metab, 2017. PMID 28123934

2017 / Interventional trial with wash-out period

Chronic branched chain amino acid supplementation impaired insulin sensitivity in vegans but not in omnivores.

Eight vegans and eight matched omnivores were supplemented with 15 g (women) or 20 g (men) of branched chain amino acids (BCAA) daily for 3 months, followed by a 6-month wash-out. Vegans had higher baseline insulin sensitivity (GIR: 9.6±2.4 vs 7.1±2.4 mg/kg/min), which declined following the intervention (change: -1.64 mg/kg/min [95% CI: -2.5 to -0.75]) and returned to baseline after wash-out (change: 1.65 mg/kg/min [95% CI: 0.75 to 2.54]). No GIR change was observed in omnivores, though omnivores showed increased expression of lipogenic genes in adipose tissue. Skeletal muscle respiratory chain activity increased in both groups.

Gojda J, Rossmeislová L, Straková R, et al. Eur J Clin Nutr, 2017. PMID 28145418

2017 / Randomized, placebo-controlled, double-blind parallel trial

Resveratrol supplementation for 16 weeks did not improve metabolic syndrome markers and high doses increased total and LDL cholesterol.

A 16-week randomized, placebo-controlled, double-blind trial investigated daily oral supplementation with 1000 mg resveratrol (RSVhigh), 150 mg resveratrol, or placebo in 74 middle-aged men with metabolic syndrome. Resveratrol did not alter circulating hs-CRP, interleukin 6, soluble urokinase plasminogen activator receptor, or inflammatory gene expression in muscle and adipose tissues, and showed no effect on blood pressure, body composition, or glucose and lipid metabolism. However, RSVhigh treatment significantly increased total cholesterol (P < 0.002), LDL cholesterol (P < 0.006), and fructosamine (P < 0.013) compared with placebo.

Kjær TN, Ornstrup MJ, Poulsen MM, et al. J Clin Endocrinol Metab, 2017. PMID 28182820

2017 / Randomized controlled crossover trial

A fasting-mimicking diet reduced body fat, blood pressure, and disease risk factors.

In a randomized trial involving 100 healthy participants, three monthly 5-day cycles of a fasting-mimicking diet reduced body weight, trunk fat, total body fat, blood pressure, and insulin-like growth factor 1. Crossover of the control group resulted in 71 participants finishing three cycles without serious adverse effects. A post hoc analysis revealed that improvements in blood pressure, fasting glucose, cholesterol, triglycerides, and C-reactive protein were greater in individuals initially at risk for disease.

Wei M, Brandhorst S, Shelehchi M, et al. Sci Transl Med, 2017. PMID 28202779

2017 / Randomized two-way crossover trial

A single night of bright light exposure significantly increased post-meal plasma glucose and insulin levels compared to dim light in healthy participants.

Seventeen healthy participants were randomized to a two-way crossover study comparing dim light (<5 lux) and bright light (>500 lux) sessions separated by at least 7 days, measuring metabolic responses around a standard evening meal. Plasma glucose and insulin levels were significantly higher post-meal during bright light compared to dim light (P = 0.02 and P = 0.001, respectively). Pre-meal plasma non-esterified fatty acid levels and salivary melatonin were significantly higher in dim light compared to bright light (P < 0.01 and P = 0.005, respectively), while plasma triglyceride levels did not differ between sessions.

Albreiki MS, Middleton B, Hampton SM Endocr Connect, 2017. PMID 28270559

2017 / Randomized controlled trial

A whole food plant-based diet reduced BMI in adults with cardiometabolic risk factors.

In a randomized controlled trial of 65 adults with overweight or obesity and cardiometabolic conditions, an ad libitum whole food plant-based diet was compared to usual care. At 6 months, mean BMI reduction was significantly greater in the diet group (difference: 3.9 kg m-2, 95% CI ±1, P < 0.0001). Total cholesterol reduction did not significantly differ between groups unless dropouts were excluded (difference: 0.56 mmol l-1, P = 0.05).

Wright N, Wilson L, Smith M, et al. Nutr Diabetes, 2017. PMID 28319109

2017 / Randomized crossover trial

Non-nutritive and sucrose-sweetened beverages showed similar 24-hour glucose profiles in healthy men

In a randomized crossover study of ten healthy men, consuming beverages sweetened with aspartame, monk fruit, stevia, or 65 g sucrose as a mid-morning preload led to no significant differences in mean 24-hour glucose, iAUC, total AUC, or 24-hour glycemic variability. Replacing one serving of a sucrose-sweetened drink with non-nutritive sweeteners had minimal influence over daily glucose measures.

Tey SL, Salleh NB, Henry CJ, et al. Eur J Clin Nutr, 2017. PMID 28378852

2017 / Randomized controlled explorative pilot trial

A 7-day fasting program reduced weight, abdominal circumference, and blood pressure in patients with type 2 diabetes at 4 months.

In an explorative trial, patients with type 2 diabetes were randomized to a 7-day fasting program (Buchinger method, ~300 kcal/day liquids) followed by dietary advice, or to usual care with dietary advice only. Of 46 enrolled participants, 32 completed the 4-month trial. After 4 months, mean weight decreased by 3.5 kg in the fasting group compared to 2.0 kg in controls (p=0.03), accompanied by a greater reduction in abdominal circumference (p=0.001). Fasting also resulted in a significant decrease in systolic (p=0.01) and diastolic (p=0.003) blood pressure, as well as increased quality of life (p=0.04), while improvements in HbA1c, insulin, and HOMA-index were non-significant.

Li C, Sadraie B, Steckhan N, et al. Exp Clin Endocrinol Diabetes, 2017. PMID 28407662

2017 / 13-day sequential laboratory intervention trial

A 5-hour delay in meal timing delayed human plasma glucose rhythms and adipose PER2 mRNA rhythms without altering central circadian markers.

Ten healthy young men completed a 13-day laboratory protocol comparing early meals (starting 0.5 hr post-wake) to late meals (starting 5.5 hr post-wake, for 6 days), followed by 37-hr constant routine assessments. Late meals did not affect master clock markers (plasma melatonin and cortisol), subjective hunger, sleepiness, plasma triglycerides, or whole blood clock gene expression. However, following late meals, plasma glucose rhythms were delayed by 5.69 ± 1.29 hr (p < 0.001), average glucose decreased by 0.27 ± 0.05 mM (p < 0.001), and adipose tissue PER2 mRNA rhythms were delayed by 0.97 ± 0.29 hr (p < 0.01).

Wehrens SMT, Christou S, Isherwood C, et al. Curr Biol, 2017. PMID 28578930

2017 / Randomized controlled trial

A hypocaloric vegetarian diet reduced subfascial thigh fat more than a conventional diet.

In a randomized trial, 74 individuals with type 2 diabetes consumed either a calorie-restricted vegetarian diet or an isocaloric conventional anti-diabetic diet for 6 months. Total leg area decreased more in the vegetarian group (-13.6 cm2 vs -9.9 cm2; p < 0.001), and subfascial fat was reduced only with the vegetarian diet (-0.82 cm2 vs -0.44 cm2; p = 0.04). Reductions in subfascial and subcutaneous fat correlated with improvements in fasting glucose and beta-cell insulin sensitivity.

Kahleova H, Klementova M, Herynek V, et al. J Am Coll Nutr, 2017. PMID 28604251